These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 16120482

  • 1. Sodium Valproate versus Propranolol in paediatric migraine prophylaxis.
    Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F.
    Eur J Paediatr Neurol; 2005; 9(5):333-8. PubMed ID: 16120482
    [Abstract] [Full Text] [Related]

  • 2. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.
    Mitsikostas DD, Polychronidis I.
    Funct Neurol; 1997; 12(5):267-76. PubMed ID: 9439944
    [Abstract] [Full Text] [Related]

  • 3. [Sodium valproate versus propranolol in the prophylactic treatment of migraine].
    Kozubski W, Prusiński A.
    Neurol Neurochir Pol; 1995; 29(6):937-47. PubMed ID: 8714731
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
    Bidabadi E, Mashouf M.
    Paediatr Drugs; 2010 Aug 01; 12(4):269-75. PubMed ID: 20593910
    [Abstract] [Full Text] [Related]

  • 5. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
    Tanen DA, Miller S, French T, Riffenburgh RH.
    Ann Emerg Med; 2003 Jun 01; 41(6):847-53. PubMed ID: 12764341
    [Abstract] [Full Text] [Related]

  • 6. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
    Dakhale GN, Sharma VS, Thakre MN, Kalikar M.
    Indian J Pharmacol; 2019 Jun 01; 51(4):255-262. PubMed ID: 31571712
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 01; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
    Afshari D, Rafizadeh S, Rezaei M.
    Int J Neurosci; 2012 Feb 01; 122(2):60-8. PubMed ID: 21950578
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G, Marková J, Mastík J.
    Neuro Endocrinol Lett; 2007 Feb 01; 28(1):59-64. PubMed ID: 17277725
    [Abstract] [Full Text] [Related]

  • 10. Valproic acid in migraine prophylaxis of young patients. Three new reports.
    Fusco C, Pisani F, Capone C, Faienza C.
    Acta Biomed; 2002 Feb 01; 73(3-4):47-51. PubMed ID: 12596387
    [Abstract] [Full Text] [Related]

  • 11. The effects of cinnarizine versus sodium valproate in migraine prophylaxis.
    Bostani A, Rajabi A, Moradian N, Razazian N, Rezaei M.
    Int J Neurosci; 2013 Jul 01; 123(7):487-93. PubMed ID: 23311688
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group.
    Headache; 2009 Feb 01; 49(2):216-26. PubMed ID: 19222595
    [Abstract] [Full Text] [Related]

  • 13. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr 01; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol.
    Togha M, Malamiri RA, Rashidi-Ranjbar N, Asa S, Mahvelati F, Ashrafi MR.
    Acta Neurol Belg; 2012 Mar 01; 112(1):51-5. PubMed ID: 22427290
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
    Ashtari F, Shaygannejad V, Akbari M.
    Acta Neurol Scand; 2008 Nov 01; 118(5):301-5. PubMed ID: 18713156
    [Abstract] [Full Text] [Related]

  • 16. Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels.
    Lenaerts M, Bastings E, Sianard J, Schoenen J.
    Acta Neurol Belg; 1996 Jun 01; 96(2):126-9. PubMed ID: 8711985
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
    Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS.
    Can J Neurol Sci; 1992 Aug 01; 19(3):340-5. PubMed ID: 1393843
    [Abstract] [Full Text] [Related]

  • 18. [Preventive treatment for migraine].
    Mulleners WM, Haan J, Dekker F, Ferrari MD.
    Ned Tijdschr Geneeskd; 2010 Aug 01; 154():A1512. PubMed ID: 20699036
    [Abstract] [Full Text] [Related]

  • 19. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura.
    Kaniecki RG.
    Arch Neurol; 1997 Sep 01; 54(9):1141-5. PubMed ID: 9311358
    [Abstract] [Full Text] [Related]

  • 20. Weight change associated with the use of migraine-preventive medications.
    Taylor FR.
    Clin Ther; 2008 Jun 01; 30(6):1069-80. PubMed ID: 18640463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.